Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Parkinson's Disease > Flashcards

Parkinson's Disease Flashcards

1
Q

etiology of PD?

A

unknown.

Loss of neurons in the substantia nigra which provide dopaminergic innervation to the striatum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe dopamine synthesis…

A

originates from tyrosine -> transport across BBB into the dopamine neuron via system L in a Na-independent manner.

tyrosine -[tyrosine hydroxylase]-> DOPA -[DOPA decarboxylase]-> dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the rate-limiting step in dopamine synthesis?

A

tyrosine hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what receptors are abundant in the striatum?

A

D1 receptors: increase adenylyl cyclase

D2 receptors: decrease adenylyl cyclase, increase K conductance, decrease Ca conductance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the pathophysiology of PD?

A

Dopa neurons from the substantia nigra normally inhibit the GABAergic output from the striatum, whereas cholinergic neurons stimulate it.

in PD, there is destruction of the neurons of the nigrostriatal pathway responsible for secreting dopa in the striatum -> loss of control of muscle movement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the strategy of tx for PD?

A

restoring dopa in the basal ganglia and antagonizing the excitatory effect of cholinergic neurons; reestablishing the correct dopa/Ach balance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the drug categories that restore dopa actions?

A
  1. dopamine precursors
  2. dopamine receptor agonists
  3. inhibitors of dopamine metabolism
  4. amantadine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the drug category for antagonists of Ach?

A
  1. antimuscarinics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the dopamine precursors?

A

levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. levodopa

chemistry?

A

steroisomer of dopa.
metabolic precursor of dopa (and NE).
restores dopa levels in extrapyramidal centers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what happens in early stage of DP with levodopa?

late stage?

A

number of residual dopaminergic neurons in the substantia nigra is enough for conversion of levodopa to dopa.

late stage, number of neurons decreased and there are few cells capable of taking up levodopa and converting it to dopa -> motor control fluctuation develops -> relief by levodopa is only symptomatic and lasts only while the drug is present in body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Levodopa

MOA?

A
  • dopa does not cross BBB, much is decarboxylated to dopa int he periphery.
  • transported into the CNS and converted to dopa in the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

levodopa

peripheral s.e?

A

nausea
vomiting
cardiac arrythmias
hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Carbidopa

MOA?

A
  • dopa decarboxylase inhibitor that does not cross BBB.
  • given in combo c levodopa to decrease metabolism of levodopa in the GI and peripheral tissues -> increase availability to the CNS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is sinemet?

A

dopa prep containing carbidopa and levodopa (1:10 or 1:4).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Levodopa

PK?

A

absorbed rapidly from the small intestine.
food delays appearance in plasma.

certain a.a can compete c the drug for absorption from the gut and for transport from the blood to brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

levodopa

metabolism?

A

levodopa -[COMT]–> 3-o-methyl dopa

dopamine -[COMT]–> 3-methoxytyramine -[MAO, aldehyde DH]–> 3-methoxy 4-hydroxyphenylacetate (HVA)

dopamine -[MAO, aldehyde DH]–> 3,4-dihydroxyphenylacetate (DOPAC) -[COMT]–> HVA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

levodopa/carbidopa

clinical uses?

A
  • efficacious drug regimen for PD
  • decline in response during the 3rd to 5th yr of therapy.
  • levodopa does not stop progression, but early initation of levodopa therapy lowers mortality d/t the disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Wearing-Off rxns (end-of-dose akineasia)?

A

fluctuations related to the timing of levodopa intake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the on-off phenomenon?

A
  • fluctuations in response unrelated to the timing of doses.
  • mechanism is unknown
  • pts c severe off-periods who are unresponsive to other measures, apomorphine SC may provide benefit.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

levodopa

interactions?

A
  • vit b6 is a cofactor of Dopa decarboxylase: increases periph metabolism of levodopa
  • concomitant adm of nonspecific MAO inhibotrs = precipitate htn crisis.
  • should not give to psychotic pts = exacerbate the mental disturbance.
22
Q

levodopa

contraindications?

A
  • angle-closure glaucoma
  • cardiac pts should be carefully monitored b/c of possible arrythmias
  • antipsychotic drugs = produce a parkinsonian syndrome.
23
Q

what is the benefit of dopamine receptor agonists?

A

don’t require enzymatic conversion for activity, therefore they do not depend on the functional capacities of the nigrostriatal neurons.

24
Q

what are the two dopamine receptor agonist categories?

A
  1. ergot dopamine agonists

2. nonergot dopamine agonists

25
Q

what is an ergot dopamine agonist?

A

bromocriptine: D2 agonist

26
Q

what are some nonergot dopamine agonists?

A
  1. pramipexole
  2. ropinirole
  3. rotigotine
27
Q

dopamine agonists

GI A.E?

A 
anorexia
nausea and vomiting
constipation
dyspepsia
bleeding from peptic ulceration
28
Q

dopamine agonists

Cardiovascular A.E?

A

postural hypotension
cardiac arrythmias
peripheral edema
ergot derivatives may cause painless digital vasospasm.

29
Q

dopamine agonists

CNS A.E?

A

dyskinesias

mental disturbances: confusion, hallucination, delusion.

30
Q

dopamine agonists

miscellaneous A.E?

A

ergot dopamine agonists:

  • pulmonary infiltrates
  • pleural and retroperitoneal fibrosis
  • erythromelalgia

Pramipexole, ropinirole, rotigotine:
-uncontrolled somnolence

31
Q

dopamine agonists

contraindications?

A
  • psychotic illness
  • recent MI
  • peripheral vascular disease
  • peptic ulceration
32
Q

what is a nonergot dopamine agonists rescue therapy?

A

apomorphine

33
Q

apomorphine

uses?

A

tx of “off” episodes of akinesia in pts on dopaminergic therapy.

34
Q

apomorphine

A.E?

A

emetogenic; pretx c an antiemetic is rec’d.

QT prolongation
dyskinesias
drowsiness
sweating
hypotension
bruising at injxn site
35
Q

what are the two inhibitors of dopamine metabolism?

A
  1. Monoamine oxidase inhibitors

2. Catechol-o-methyltransferase inhibitors

36
Q

what are the monoamine oxidase inhibitors?

A
  1. deprenyl (selegiline)

2. Rasagiline

37
Q

deprenyl (selegiline)

MOA?

A

selective/irreversible inhibits MAO-B -> retards breakdown of dopamine in brain.

enhances effect of levodopa (can reduce dosage c combo)
used adjunct to levodopa.

38
Q

deprenyl (selegiline)

A.E?

A

metabolized to methamphetamine and amphetamine: may cause insomnia if taken late in the day.

39
Q

rasagiline

MOA?

A

MAO-B inhibitor

40
Q

what happens to COMT when given carbidopa to inhibit Dopa decarboxylase?

A

compensation activation of COMT pathway -> increases plasma levels of 3-o-methydopa -> competes c levodopa for an active carrier that transports levodopa across the intestinal mucosa and BBB.

41
Q

what are the two COMT inhibitors?

A
  1. tolcapone

2. entacapone

42
Q
  1. tolcapone
  2. entacapone

effects?

A
  1. decreased metabolism of levodopa
  2. decreased plasma levels of 3-o-methyldopa
  3. increased uptake of levodopa
  4. higher dopamine levels in brain.
43
Q
  1. tolcapone
  2. entacapone

A.E?

A

tocapone: fulminating hepatic necrosis
entacapone: not hepatotoxic (preferred).

44
Q

Amantadine

what is it?

A

antiviral drug c antiparkinsonian actions.

45
Q

Amantadine

MOA?

A

increases synthesis, release or re-uptake of dopamine from the surviving neurons.

less efficacious than levodopa and tolerance develops more readily, but few s.e’s.

46
Q

Amantadine

A.E?

A

restlessness
agitation
confusion
hallucinations

high dose: acute toxic psychosis
peripheral edema - response to diuretics

livedo reticularis

47
Q

Amantadine

contraindications?

A

pts c a hx of seizures or HF.

48
Q

What is the use of antimuscarinics in PD?

A
  • adjuvant therapy.

- improve tremor and rigidity, little on bradykinesia

49
Q

antimuscarinics

A.E?

A 
mood changes
xerostomia
pupillary dilation
confusion
hallucinations
urinary retention
50
Q

antimuscarinics

contraindications?

A

pts c glaucoma, prostatic hypertrophy or pyloric stenosis

51
Q

what is PD choice of tx?

A

best: levodopa + carbidopa
next best: dopamine agonists

addition of a COMT inhibitor or a MAO-B inhibitor to levodopa can reduce motor fluctuations in pts c advanced disease

antimusc can be useful addition to levodopa for control of tremor and drooling

52
Q

parkinson characteristics?

A

resting tremor
muscular rigidity
bradykinesia
gait impairment

Pharmacology (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions